Microbot Medical ( (MBOT)) has shared an announcement. Microbot Medical Inc. is a commercial-stage medical device company specializing in robotic solutions for endovascular procedures, led by its ...

HINGHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that Harel Gadot, ...

An Indian university is facing backlash after one of its professors was caught falsely presenting a Chinese-made robot dog at a major artificial intelligence summit, it has reportedly since been asked ...

When you hear the word robotics, you probably think of factory machines or humanoid robots sprinting across a test track. That image makes sense. For years, robotics lived in labs and industrial ...

HINGHAM, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced today that Tampa ...

A row has erupted at the India AI Impact Summit 2026, after Galgotias University showcased 'Orion', a Chinese-made robotic dog as a product developed by the its Centre of Excellence. The robot in ...

Global Robotic Leaders Convene to Discuss & Highlight Surgical Advancements of the Next Decade with a Special Focus on the Endovascular Space HINGHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Microbot ...

An Indian university has been forced to vacate its stall at this week’s flagship AI summit after falsely claiming to have developed a robot dog – which turned out to have been made in China. Online ...

Sammy Azdoufal used Claude Code to build an app to link his brand-new DJI Romo vacuum to a PS5 controller. Then he noticed something strange. The app wasn’t just controlling his vacuum. It was ...

NEW DELHI, Feb 18 (Reuters) - An Indian university has been asked to vacate its stall at the country's flagship AI summit after a staff member was caught presenting a commercially available robotic ...

Investing.com - H.C. Wainwright reiterated a Buy rating and $12.00 price target on Microbot Medical (NASDAQ:MBOT) shares following the company’s announcement of hospital adoption in Florida. The stock ...